Azenta (AZTA) vs Pulse Biosciences (PLSE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Pulse Biosciences (PLSE) has outperformed Azenta (AZTA) over the past year, gaining 150.7% versus a gain of 11.7%. Over five years, PLSE leads with a +130.9% price change compared with -65.2% for AZTA. Pulse Biosciences is the larger company by market cap ($3.56 billion vs $1.58 billion), about 2.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AZTA | PLSE |
|---|---|---|
| Share price | $36.00 | $49.98 |
| Market cap | $1.58B | $3.56B |
| 1-day change | +0.31% | +1.81% |
| YTD return | +8.24% | +264.02% |
| 1-year return | +11.70% | +150.65% |
| 5-year return | -65.20% | +130.85% |
| Forward P/E | 65.16 | — |
| EPS (TTM) | $-2.47 | $-1.18 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $350.00K |
| Net income (latest FY) | — | $-72.78M |
| Gross margin | — | -54.00% |
| Operating margin | — | -21982.57% |
| Net margin | — | -20794.57% |
| 52-week high | $46.41 | $58.90 |
| 52-week low | $15.93 | $12.56 |
| Distance from 52-week high | -22.43% | -15.14% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +2.78% | +13.05% |
| Average volume | 875.72K | 502.81K |
| Shares outstanding | 43.81M | 71.32M |
| Employees | 2,900 | 116 |
| Sector | Technology | Health Care |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Pulse Biosciences is about 2.3 times larger than Azenta by market value ($3.56B vs $1.58B).
- PLSE has outperformed AZTA by 139.0 percentage points over the past year.
- The two companies sit in different sectors: Azenta in Technology and Pulse Biosciences in Health Care.
About Azenta
AZTA stock →Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.
Technology · Industrial Machinery/Components · 2,900 employees
About Pulse Biosciences
PLSE stock →Pulse Biosciences, Inc. operates as a novel bioelectric medicine company.
Health Care · Medical/Dental Instruments · 116 employees
AZTA vs PLSE FAQ
Which is bigger, Azenta or Pulse Biosciences?
Pulse Biosciences (PLSE) is larger, with a market capitalization of $3.56B compared with $1.58B for Azenta (AZTA).
Which stock has performed better over the past year, AZTA or PLSE?
PLSE returned +150.65% over the past 12 months, compared with +11.70% for AZTA (price return, excluding dividends). Past performance does not predict future results.
Are Azenta and Pulse Biosciences in the same industry?
No. Azenta is in the Technology sector, while Pulse Biosciences is in Health Care.